Governance & policies
There are two key groups involved in the governance of CHRISP.
Executive Steering Committee
The CHRISP Executive Steering Committee is a joint UOW and ISLHD group which oversees the CHRISP research team and the CHRISP research partnership. The Committee is responsible for the strategic and executive management of the CHRISP, including all governance issues. The committee members are:
- Chief Executive ISLHD (Chair): Ms Margot Mains
- Director AHSRI, UOW: Professor Kathy Eagar
- Clinical Director: Health and Medical Research, ISLHD: Associate Professor Bruce Ashford
- Deputy Director AHSRI, UOW: Associate Professor Rob Gordon
- School of Medicine, UOW: TBA
- Executive Director, Medical Services, ISLHD: Dr Peter Jansen
The CHRISP Consultative Panel is an advisory panel responsible for providing project-specific expert advice on an as-needs basis, in three main areas: clinical issues and research priorities; data / information; and community perspectives. The Consultative Panel reports to the CHRISP Executive Steering Committee.
The Consultative Panel membership is:
- CHRISP Director (chair / convenor)
- ISLHD Manager, Planning & Commissioning Unit
- ISLHD Stream Leader, Ambulatory & Primary Health Care Division
- ISLHD Public Health Epidemiologist
- CHRISP Clinical Epidemiologist
- ISLHD Manager Information Management Unit
- ISLHD Manager, Performance Unit
- CHRISP Statistician
- CHRISP Integration & Development Coordinator
- ISLHD Community Participation Council members.
Other officers may attend these meetings as required.
Policies and guidelines
A set of policies and guidelines have been developed which detail the governance, approvals and processes under which the CHRISP team undertakes research and facilitates access to data for research. Three of these key documents are the CHRISP Data Policy, Prioritisation Policy and Authorship Guidelines. Each of these is detailed below.
The CHRISP Data Policy aims to ensure scientific rigour of research and evaluation using IHIP data and infrastructure, ensure ethical integrity including protecting against potential infringements of privacy and breaches of confidentiality, and communicate the principles and processes of the CHRISP Research Partnership with researchers, clinicians, other ISLHD staff, and third-party data contributors. It sets out the principles and processes relating to IHIP that govern:
- data ownership
- data submission and linkage
- data storage and security
- datasets and data items
- data quality
- data access
- reporting and publication using IHIP data
- data destruction and disposal.
The CHRISP Prioritisation Policy is used to assess and recommend to the CHRISP Executive Steering Committee, the relative priority of research proposals to access IHIP data and infrastructure. Priority for access to IHIP data and infrastructure for research is assessed according to the following criteria:
- Alignment with Local Health District priorities (25%)
- Potential impact of findings and translation into policy and practice (15%)
- Capability and capacity building (15%)
- Strength, rigour and appropriateness of research design (15%)
- Research output (15%)
- Resource implications (15%)
The CHRISP Authorship Guidelines provide advice to authors when publishing research using IHIP data. When IHIP data have been used for research purposes, it is expected that there will be at least one author from the Centre for Health Research Illawarra Shoalhaven Population (CHRISP) on the research publication. Authorship is attributed to persons responsible for the intellectual content of a publication. To be named as author, a researcher must have made a substantial intellectual contribution to the publication and be able to take responsibility for at least that part of the publication to which they have contributed. The authorship of a publication is a matter that should be discussed among investigators at the earliest stages of a research project and be re-assessed at any time that there is a change in research collaborations.